These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6877796)

  • 1. A morphological study of the lesions of African horsesickness.
    Newsholme SJ
    Onderstepoort J Vet Res; 1983 Mar; 50(1):7-24. PubMed ID: 6877796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An outbreak of African horsesickness in dogs.
    Van Rensberg IB; De Clerk J; Groenewald HB; Botha WS
    J S Afr Vet Assoc; 1981 Dec; 52(4):323-5. PubMed ID: 7341783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of African horse sickness: ultrastructural study of the capillaries in experimental infection.
    Gómez-Villamandos JC; Sánchez C; Carrasco L; Laviada MM; Bautista MJ; Martínez-Torrecuadrada J; Sánchez-Vizcaíno JM; Sierra MA
    J Comp Pathol; 1999 Aug; 121(2):101-16. PubMed ID: 10405303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of virulence variants of African horsesickness virus.
    Laegreid WW; Skowronek A; Stone-Marschat M; Burrage T
    Virology; 1993 Aug; 195(2):836-9. PubMed ID: 8337849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pulmonary intravascular macrophages in the pathogenesis of African horse sickness.
    Carrasco L; Sánchez C; Gómez-Villamandos JC; Laviada MD; Bautista MJ; Martínez-Torrecuadrada J; Sánchez-Vizcaíno JM; Sierra MA
    J Comp Pathol; 1999 Jul; 121(1):25-38. PubMed ID: 10373291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron microscopic evidence for endothelial infection by African horsesickness virus.
    Laegreid WW; Burrage TG; Stone-Marschat M; Skowronek A
    Vet Pathol; 1992 Nov; 29(6):554-6. PubMed ID: 1448905
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pathology and hemostatic abnormalities in experimental African horsesickness.
    Skowronek AJ; LaFranco L; Stone-Marschat MA; Burrage TG; Rebar AH; Laegreid WW
    Vet Pathol; 1995 Mar; 32(2):112-21. PubMed ID: 7771050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
    Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
    Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of African horsesickness: duration of viraemia in zebra (Equus burchelli).
    Barnard BJ; Bengis R; Keet D; Dekker EH
    Onderstepoort J Vet Res; 1994 Dec; 61(4):391-3. PubMed ID: 7501371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the transmission of African horsesickness.
    Wetzel H; Nevill EM; Erasmus BJ
    Onderstepoort J Vet Res; 1970 Sep; 37(3):165-8. PubMed ID: 5526278
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
    von Teichman BF; Smit TK
    Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of different African horsesickness virus serotypes in the Onderstepoort area near Pretoria, during an outbreak of African horsesickness in South Africa in 1995/1996.
    Bremer CW; Gerdes GH; Aitchison H; Louw I; Greyling RR; Welgemoed J
    Onderstepoort J Vet Res; 2000 Mar; 67(1):65-70. PubMed ID: 10843324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
    Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
    Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Isobutyraldehyde (CAS No. 78-84-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 472():1-242. PubMed ID: 12579201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of cavian viral leukemia.
    Opler SR
    Am J Pathol; 1967 Dec; 51(6):1135-51. PubMed ID: 6064903
    [No Abstract]   [Full Text] [Related]  

  • 18. African horse sickness--a serious disease.
    Aust Vet J; 2006 May; 84(5):N24-5. PubMed ID: 16739521
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of the nonstructural protein NS3 of African horsesickness virus.
    Stoltz MA; van der Merwe CF; Coetzee J; Huismans H
    Onderstepoort J Vet Res; 1996 Mar; 63(1):57-61. PubMed ID: 8848304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.